On February 3, 2022 Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult-to-treat cancers, reported that the company will present at the Guggenheim Healthcare Talks, 2022 Oncology Conference, taking place virtually February 9-February 11, 2022 (Press release, Sapience Therapeutics, FEB 3, 2022, View Source [SID1234607720]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Barry Kappel, CEO and President of Sapience, will present a company overview on Friday February 11th, at 11:30 am ET. Sapience management will also participate in one-on-one meetings with investors during the conference.